Home › Funds › Perpetual Ltd › GEHC
Perpetual Ltd position in GEHC
GE HEALTHCARE TECHNOLOGIES I · Health Care
Perpetual Ltd reported holding 2,712,232 shares of GEHC (GE HEALTHCARE TECHNOLOGIES I) in its Q3 2026 13F filing — a position valued at US$177.3M, representing 2.70% of its reported portfolio and ranking #8 among its reported holdings. Perpetual Ltd has disclosed GEHC holdings in 9 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Perpetual Ltd's GEHC position evolved
Perpetual Ltd first disclosed a stake in GEHC in Q1 2024 at 1,057,473 shares (US$96.1M). The position peaked in Q3 2026 at 2,712,232 shares, worth US$177.3M. Across 9 filings, Perpetual Ltd increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,712,232 shares valued at US$177.3M — an increase of 1,404,683 shares quarter over quarter.. Notable position changes include a 46% increase in Q2 2024 (shares rose 21% over the following quarter), a 118% increase in Q1 2026 (shares fell 11% over the following quarter), a 107% increase in Q3 2026 (shares rose 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 1.06M | $96.13M | New |
| Q2 2024 | 1.54M | $120.00M | Add |
| Q3 2024 | 1.39M | $130.83M | Reduce |
| Q4 2024 | 1.30M | $101.89M | Reduce |
| Q1 2025 | 1.35M | $109.33M | Add |
| Q4 2025 | 459.11K | $37.66M | New |
| Q1 2026 | 999.38K | $71.14M | Add |
| Q2 2026 | 1.31M | $83.70M | Add |
| Q3 2026 | 2.71M | $177.30M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GEHC and 13F data
GEHC (GE HEALTHCARE TECHNOLOGIES I) is a Health Care company. 27 other funds we track also report a position in GEHC — the largest reported positions include Dodge & Cox (US$2.42B), DODGE & COX (US$2.42B), Harris Associates (Oakmark) (US$981.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GEHC
- Dodge & Cox 37.86M sh · $2.42B · Q2 2026
- DODGE & COX 37.86M sh · $2.42B · Q2 2026
- Harris Associates (Oakmark) 15.33M sh · $981.25M · Q2 2026
- HARRIS ASSOCIATES L P 15.33M sh · $981.25M · Q2 2026
- BARROW HANLEY MEWHINNEY & STRAUSS LLC 13.46M sh · $861.31M · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 12.25M sh · $784.15M · Q2 2026
- TRIAN FUND MANAGEMENT, L.P. 3.09M sh · $197.49M · Q2 2026
FAQ
How long has Perpetual Ltd held GEHC?
Perpetual Ltd has disclosed GEHC holdings in 9 of the last 11 reported quarters, going back to Q1 2024.
What is Perpetual Ltd's current position in GEHC?
As of Q3 2026, Perpetual Ltd holds 2.71M shares of GEHC (GE HEALTHCARE TECHNOLOGIES I), valued at $177.30M, representing 2.70% of its reported portfolio and ranking #8.
Has Perpetual Ltd been buying or selling GEHC?
In the latest 13F filing (Q3 2026), Perpetual Ltd increased its position in GEHC. The position peaked in Q3 2026 at 2.71M shares.
Which other funds hold GEHC?
Other major institutional holders of GEHC include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.